期刊文献+

氟伐他汀对原发性高血压肾损害尿蛋白的影响

The Fluorine Cuts Down His Sandbank to Hypertension Kidney Harm Urine Protein Influence
下载PDF
导出
摘要 目的:观察氟伐他汀对血压控制正常的原发性高血压肾损害患者尿蛋白的影响。方法:60例血压控制正常的原发性高血压肾损害患者随机分为氟伐他汀组(30例)或对照组(30例),分别给予氟伐他汀(40mg)或安慰剂治疗6个月,观察血压(SBP/DBP),血脂(TG、TC)、肌酐(Cr)、24h尿蛋白(U-Pro)变化。结果:治疗6月后,氟伐他汀组的TC.U-Pro较对照组均显著降低(P<0.05),而两组间的SBP/DBP、TG、Cr无明显改变(P>0.05)。结论:氟伐他汀可减少原发性高血压肾损害的尿蛋白。 Objective The observation fluorine cuts down his sandbank to harm the patient to the blood pressure control normal hypertension kidney to urinate the protein influence. Methods 60 examples blood pressure control normal hypertension kidney harms the patient to divide into the fluorine to cut down his sandbank group stochastically (30 examples) or the control group (30 examples), Separately gives the fluorine to cut down his sandbank (40mg) or the placebo treats for 6 months, Observation blood pressure (SBP/DBP), blood fats (TG, TC), myobitter wine (Cr), 24 h urine protein (U-Pro) change.Results After treatment in June, the fluorine cuts down his sandbank group TC. U-Pro compares the control group obviously to reduce (P〈0.05), but two group of between SBP/DBP, TG, Cr change not obviously (P〉0.05).Conclusion The fluorine cuts down his sandbank to be possible to reduce hypertension.
作者 李艳芳
机构地区 南溪人民医院
出处 《实用医技杂志》 2008年第1期24-25,共2页 Journal of Practical Medical Techniques
关键词 氟伐他汀 尿蛋白 原发性高血压 The fluorine cuts down his sandbank Urine protein Hypertension sickness
  • 相关文献

参考文献2

二级参考文献28

  • 1Braunwald E.Cardiovascular medicine at the turn of the millennium:triumphs,concerns,and opportunities[J].N Engl J Med,1997,337:1360-1369. 被引量:1
  • 2Heart Protection Study Collaborative Group.MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals:a randomized placebo-controlled trial[J].Lancet,2002,360:7-22. 被引量:1
  • 3The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID)Study Group.Prevention of cardiovascular events and death with pravastatin inpatients with coronary heart disease and a broad range of initial cholesterol lev-els[J].N Engl J Med,1998,339:1349-1357. 被引量:1
  • 4Downs JR,Clearfield M,Weis S,et al.For the AFCAPS/TexCAPS Research Group,Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS[J].JAMA,1998,279:1615-1622. 被引量:1
  • 5Sever PS,Dahlof B,Poulter NR,et al.For the ASCOT Investigators.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations,in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):a multicentre randomized controlled trial[J].Lancet,2003,361:1149-1158. 被引量:1
  • 6Stein DT,Devaraj S,Balis D,et al.Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia[J].Arterioscler Thromb Vasc Biol,2001,21:2026-2031. 被引量:1
  • 7Wolfrum S,Jensen KS,Liao JK.Endothelium-dependent effects of statins[J].Arterioscler Thromb Vasc Biol,2003,23:1-8. 被引量:1
  • 8Takemoto M,Liao JK.Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors[J].Arterioscler Thromb Vasc Biol,2001,21:1712-1719. 被引量:1
  • 9Rasmussen LM,Hansen PR,Nabipour MT,et al.Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells[J].Biochem J,2001,360:363-370. 被引量:1
  • 10Rosenson RS,Tangney CC,Casey LC.Inhibition of proinflammatory cytokine production by pravastatin[J].Lancet,1999,353:983-984. 被引量:1

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部